GUMERSINDO
PÉREZ MANGA
Forscher bis um 2009
University of Texas MD Anderson Cancer Center
Houston, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von University of Texas MD Anderson Cancer Center (2)
2004
-
Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: Integrated efficacy data and novel analyses from two large, randomised, phase III trials
British Journal of Cancer, Vol. 90, Núm. 6, pp. 1190-1197
2002
-
First-line oral capecitabine therapy in metastatic colorectal cancer: A favorable safety profile compared with intravenous 5-fluorouracil/leucovorin
Annals of Oncology, Vol. 13, Núm. 4, pp. 566-575